Connecticut Business Herald
SEE OTHER BRANDS

Following business and economy news from Connecticut

Connecticut Business Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Connecticut Business Herald.

Press releases published on June 3, 2025

OXB Highlights the Launch of its Innovation and Technology Excellence Board

OXB Highlights the Launch of its Innovation and Technology Excellence Board

Oxford, UK – 03 June 2025: OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, today highlights the launch of its Innovation and Technology Excellence Board (ITEB). The ITEB brings together leading experts in …

Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …

Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …

Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors

Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors

BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the appointment of Maha Radhakrishnan, M.D., to its Board of Directors. “We are pleased to have Dr. Radhakrishnan join the Board at this time of tremendous …

NIRI Twin Cities Chapter Elects 2025-2026 Board of Directors

NIRI Twin Cities Chapter Elects 2025-2026 Board of Directors

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- The Twin Cities Chapter (www.niri-twincities.org) of the National Investor Relations Institute (NIRI) today announced the election of its officers and directors for the 2025-2026 program year, which begins …

Chicago Atlantic BDC, Inc. Announces 2025 Annual Meeting of Stockholders’ Date

Chicago Atlantic BDC, Inc. Announces 2025 Annual Meeting of Stockholders’ Date

NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (“LIEN” or the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, announced on April 30, 2025 that its annual …

Next Hydrogen announces transition of its COO to a consulting arrangement

Next Hydrogen announces transition of its COO to a consulting arrangement

MISSISSAUGA, Ontario, June 03, 2025 (GLOBE NEWSWIRE) -- Next Hydrogen Solutions Inc. (“Next Hydrogen“) (TSXV:NXH, OTC:NXHSF) announces that James Franchville, the company’s Chief Operating Officer, will be stepping down from his role and transitioning into …

I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series

I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series

ROCKVILLE, Md., June 03, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s …

New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve

New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve

PRINCETON, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the publication of a post-hoc analysis of data from the ERT-experienced cohort of the PROPEL study of cipaglucosidase alfa-atga + miglustat (cipa+mig) in …

Brookfield Announces Reset Dividend Rate on Its Series 42 Preference Shares

Brookfield Announces Reset Dividend Rate on Its Series 42 Preference Shares

All amounts in Canadian dollars unless otherwise stated. BROOKFIELD, NEWS, June 03, 2025 (GLOBE NEWSWIRE) -- Brookfield Corporation (“Brookfield”) (NYSE: BN, TSX: BN) today announced that it has determined the fixed dividend rate on its Cumulative Class A …

Conavi Medical Announces New Grant of Stock Options

Conavi Medical Announces New Grant of Stock Options

TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), announced that its board of directors (the “Board”) has approved grants of stock options (the “Stock Options”) Plan on June 2, …

Sultran Ltd. Celebrates 50 Years of Industry Leadership and Innovation

Sultran Ltd. Celebrates 50 Years of Industry Leadership and Innovation

CALGARY, Alberta, June 03, 2025 (GLOBE NEWSWIRE) -- Sultran Ltd., a Canadian leader in bulk commodity logistics, proudly marks its 50th anniversary this year, celebrating five decades of industry leadership, innovation, and reliability in transporting …

BeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at 2025 ASCO Annual Meeting

BeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at 2025 ASCO Annual Meeting

Median PFS at 6.8 months, Disease Control Rate of 77.3%, 15 months OS% at 78% in Metastatic NSCLC Patients after Progression on PD-1/L1 Therapies FLORHAM PARK, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the …

QuantaSing to Report Third Fiscal Quarter Financial Results on June 6, 2025

QuantaSing to Report Third Fiscal Quarter Financial Results on June 6, 2025

BEIJING, June 03, 2025 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading lifestyle solution provider empowering adults to live better and longer, today announced that it plans to release its unaudited …

OvalEdge positioned as a Leader and Emerging Innovator in the 2025 SPARK Matrix: Data Governance Solutions by QKS Group

OvalEdge positioned as a Leader and Emerging Innovator in the 2025 SPARK Matrix: Data Governance Solutions by QKS Group

Middleton, Massachusetts, June 03, 2025 (GLOBE NEWSWIRE) -- The QKS Group SPARK Matrix™ provides competitive analysis …

Bitget Launches Second Year of Anti-Scam Month Campaign to Fight Growing Cyber Fraud

Bitget Launches Second Year of Anti-Scam Month Campaign to Fight Growing Cyber Fraud

VICTORIA, Seychelles, June 03, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has officially launched the second year of its Anti-Scam Month, a global initiative run to spread crypto security awareness. In a world …

VEON and Engro Corporation Complete Pioneering Infrastructure Partnership in Pakistan

VEON and Engro Corporation Complete Pioneering Infrastructure Partnership in Pakistan

Islamabad and Dubai, June 3, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or “the Company”), announces that it has successfully closed the partnership for the pooling and management of telecommunications infrastructure assets in …

Greenbacker delivers first quarter results

Greenbacker delivers first quarter results

Company announces year-over-year increases in IPP revenue, power production, and generation capacity in its operating fleet, as well as construction milestones on largest solar project in New York Key Takeaways Against a backdrop of trade policy driven …

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

WILMETTE, Ill., June 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today …

FactSet Announces CEO Succession Plan

FactSet Announces CEO Succession Plan

Sanoke Viswanathan Appointed Chief Executive Officer Effective Early September 2025 Phil Snow to Retire After Accomplished 30-Year Career with FactSet, Including 10 Years as CEO NORWALK, Conn., June 03, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service